JP2011178784A5 - - Google Patents

Download PDF

Info

Publication number
JP2011178784A5
JP2011178784A5 JP2011034961A JP2011034961A JP2011178784A5 JP 2011178784 A5 JP2011178784 A5 JP 2011178784A5 JP 2011034961 A JP2011034961 A JP 2011034961A JP 2011034961 A JP2011034961 A JP 2011034961A JP 2011178784 A5 JP2011178784 A5 JP 2011178784A5
Authority
JP
Japan
Prior art keywords
water
results
shows
particles
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011034961A
Other languages
English (en)
Japanese (ja)
Other versions
JP5616251B2 (ja
JP2011178784A (ja
Filing date
Publication date
Priority claimed from GB0305322A external-priority patent/GB0305322D0/en
Application filed filed Critical
Publication of JP2011178784A publication Critical patent/JP2011178784A/ja
Publication of JP2011178784A5 publication Critical patent/JP2011178784A5/ja
Application granted granted Critical
Publication of JP5616251B2 publication Critical patent/JP5616251B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011034961A 2003-02-12 2011-02-21 固形腫瘍の化学的塞栓療法用組成物 Expired - Lifetime JP5616251B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03250868 2003-02-12
EP03250868.1 2003-02-12
GB0305322.0 2003-03-07
GB0305322A GB0305322D0 (en) 2003-03-07 2003-03-07 Chemoembolisation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006500252A Division JP4895802B2 (ja) 2003-02-12 2004-02-12 固形腫瘍の化学的塞栓療法用組成物

Publications (3)

Publication Number Publication Date
JP2011178784A JP2011178784A (ja) 2011-09-15
JP2011178784A5 true JP2011178784A5 (enExample) 2012-05-17
JP5616251B2 JP5616251B2 (ja) 2014-10-29

Family

ID=32870779

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006500252A Expired - Lifetime JP4895802B2 (ja) 2003-02-12 2004-02-12 固形腫瘍の化学的塞栓療法用組成物
JP2011034961A Expired - Lifetime JP5616251B2 (ja) 2003-02-12 2011-02-21 固形腫瘍の化学的塞栓療法用組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006500252A Expired - Lifetime JP4895802B2 (ja) 2003-02-12 2004-02-12 固形腫瘍の化学的塞栓療法用組成物

Country Status (9)

Country Link
EP (1) EP1592405B1 (enExample)
JP (2) JP4895802B2 (enExample)
KR (1) KR101157260B1 (enExample)
CN (4) CN103393605B (enExample)
AT (1) ATE396708T1 (enExample)
DE (1) DE602004014101D1 (enExample)
ES (1) ES2308149T3 (enExample)
HK (1) HK1079980B (enExample)
WO (1) WO2004071495A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072281A2 (en) 2000-03-24 2001-10-04 Biosphere Medical Inc. Microspheres for active embolization
WO2005087193A2 (en) * 2004-03-11 2005-09-22 Biocompatibles Uk Limited Chemoembolisation involving an anthracycline compound
ES2361919T3 (es) * 2004-09-07 2011-06-24 Biocompatibles Uk Limited Suministro de fármaco a partir de agentes embólicos.
CN101237857A (zh) 2005-05-09 2008-08-06 生物领域医疗公司 使用微球和非离子型造影剂的组合物和方法
JP5075130B2 (ja) * 2006-01-24 2012-11-14 バイオコンパティブルズ ユーケー リミテッド ポリマー粒子を薬物で負荷する方法
WO2007090127A2 (en) 2006-01-30 2007-08-09 Surgica Corporation Compressible intravascular embolization particles and related methods and delivery systems
EP2034951B2 (en) * 2006-06-22 2020-03-25 Biocompatibles UK Limited Rehydratable pharmaceutical product
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
US8940334B2 (en) 2007-05-11 2015-01-27 Nerviano Medical Sciences S.R.L. Pharmaceutical composition of an anthracycline
ES2706023T3 (es) * 2007-08-16 2019-03-27 Biocompatibles Uk Ltd Administración de combinaciones de fármacos
US20110293672A1 (en) * 2008-12-02 2011-12-01 Biocompatibles Uk Limited Pancreatic tumour treatment
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
JP5957610B2 (ja) 2012-08-31 2016-07-27 チュンアン ユニバーシティー インダストリー アカデミック コアポレイション ファウンデイション 塞栓用のミクロスフェアの製造方法及び薬物含有ナノ輸送体が結合されたミクロスフェアの製造方法
WO2014152488A2 (en) 2013-03-15 2014-09-25 Dreher Matthew R Imageable embolic microsphere
GB2519738A (en) * 2013-09-06 2015-05-06 Biocompatibles Uk Ltd Radiopaque polymers
GB2521997A (en) 2013-09-06 2015-07-15 Biocompatibles Uk Ltd Radiopaque polymers
WO2016139606A1 (en) 2015-03-02 2016-09-09 Accurate Medical Therapeutics Ltd. Preventing non-target embolization
GB201515602D0 (en) 2015-09-03 2015-10-21 Biocompatibles Uk Ltd Polymers and microspheres
WO2017158482A1 (en) 2016-03-14 2017-09-21 Biocompatibles Uk Limited Emulsion comprising particles
ES2865433T3 (es) 2016-05-04 2021-10-15 Accurate Medical Therapeutics Ltd Cabezal de microcatéter de embolización que tiene un patrón ranurado
EP3541368B1 (en) 2016-11-16 2023-07-12 The United States of America, as represented by the Secretary, Department of Health and Human Services Imageable particles, methods of making and methods of use thereof
CN110891550B (zh) 2017-07-13 2023-03-07 瓦里安医疗系统公司 栓塞微球
JP7364193B2 (ja) 2017-11-02 2023-10-18 アキュレイト メディカル セラピューティクス リミテッド 内蔵フィルタを有する塞栓術用カテーテル
US11702498B2 (en) 2018-06-29 2023-07-18 Biocompatibles Uk Limited Radiopaque polymers
EP3941437A1 (en) 2019-03-22 2022-01-26 Biocompatibles UK Limited Embolic microspheres and methods
US12433600B2 (en) 2019-05-23 2025-10-07 Argon Medical Devices, Inc. Embolization catheter for reflux free delivery of microspheres
GB201910286D0 (en) 2019-07-18 2019-09-04 Biocompatibles Uk Ltd Radiopaque polymers
CN115484961A (zh) * 2020-02-25 2022-12-16 海必恩制药公司 环孢菌素类似物用于治疗癌症的用途
CN114099442B (zh) * 2020-08-25 2024-01-30 复旦大学 用于肿瘤放化疗栓塞治疗和影像的多功能微球制剂及其制备方法
CN113797383A (zh) * 2021-09-28 2021-12-17 迪格瑞医疗科技(苏州)有限公司 一种高弹性、高载药量的栓塞微球及其制备方法
JP2025501572A (ja) 2021-12-23 2025-01-22 ボストン サイエンティフィック メディカル デバイス リミテッド 化学塞栓用組成物とそれを使用する治療方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978713A (en) * 1987-12-16 1990-12-18 Ciba-Geigy Corporation Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom
JP3041627B2 (ja) * 1989-04-13 2000-05-15 武田薬品工業株式会社 アントラサイクリン系抗生物質の安定組成物
JPH06329542A (ja) * 1993-05-21 1994-11-29 Kibun Food Chemifa Co Ltd 不溶性アルギン酸塩粒子を含む局所血管止血用組成物および動脈化学塞栓用組成物
JP4619457B2 (ja) * 1993-11-18 2011-01-26 シルテックス、メディカル、リミテッド 徐放性製剤
AU8877098A (en) * 1997-09-05 1999-03-29 Nycomed Imaging As Polymer particles made of polyvinyl alcohol and comprising contrast agent for chemoembolization
WO2001068720A1 (en) * 2000-03-13 2001-09-20 Biocure, Inc. Embolic compositions
EP1325046B1 (en) * 2000-10-06 2007-06-27 Biocompatibles UK Limited Zwitterionic polymers
US20060165804A1 (en) * 2002-09-25 2006-07-27 Lewis Andrew L Polymer compositions for administration to animals

Similar Documents

Publication Publication Date Title
JP2011525477A5 (enExample)
JP2015205922A5 (enExample)
ES2688889T3 (es) Proceso de mezcla sin disolvente para el recubrimiento de ingredientes farmacéuticos
RU2015128609A (ru) Перенасыщенные стабилизированные наночастицы для слаборастворимых лекарственных средств
RU2011102777A (ru) Частицы с покрытием, содержащие фармацевтически активные агенты
JP2010090168A5 (enExample)
JP2015511953A5 (enExample)
JP2011529039A5 (enExample)
JP2014005302A5 (enExample)
MX2008014456A (es) Procedimiento para preparar microesferas para liberacion sostenida que tienen capacidad mejorada de dispersion y capacidad de inyeccion.
JP2008280351A5 (enExample)
JP2010537989A5 (enExample)
JP2012176990A5 (enExample)
JP2014528431A5 (enExample)
WO2009034541A3 (en) Controlled release pharmaceutical dosage forms of trimetazidine
RU2014101227A (ru) Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм
JP2017536401A5 (enExample)
FI3263110T3 (fi) Tabletti, joka käsittää metoksiureajohdannaista ja mannitolipartikkeleita
WO2010017215A3 (en) Biodegradable microspheres and methods of use thereof
JP2017537168A5 (enExample)
WO2006097558A3 (es) Nanopartículas de quitosano y polientilenglicol como sistema de administración de moléculas biológicamente activas
JP2010540547A5 (enExample)
Murtaza et al. Evaluation of cefixime-loaded chitosan microspheres: Analysis of dissolution data using DDSolver
JP2015508411A5 (enExample)
JP2015510935A5 (enExample)